Over the last decade, significant methodological and conceptual advances in life sciences have enabled the development of the so-called new biology.
The new biology is mainly based on the ability to study cells at a molecular level thanks to the increasing availability of genomic sequences of many species and to the possibility to determine, in a comprehensive way, gene expression profiles as well as the interactions between biological macromolecules. In addition, technological advances in genetic engineering and synthetic biology have led to an increased capacity for designing and building new biological systems with applications in biomedicine.
Finally, the strong development of bioinformatics and computational biology is providing new tools for the management, interpretation, and modeling of a constantly increasing amount of biological data.
The Master's degree program in Cellular and Molecular Biotechnology is therefore aimed at the training of experts in cellular and molecular biotechnology with an in-depth focus on genomic approaches in the fields of cancer biology and neurobiology and with a view to experimental, technological, and computational aspects.
The Master’s degree program in Cellular and Molecular Biotechnology (MCMB) is a two-year full-time program taught in English, which aims at training modern biotechnologists.
The courses in the MCMB program are structured to focus on the latest advances in genomics and genetic engineering in the biomedicine field with specific reference to technological aspects including advanced imaging, next-generation sequencing, high-throughput screening, and gene and cell therapy. Along with high quality and dynamic teaching, the Master’s degree program in Cellular and Molecular Biotechnology provides practical experience in state-of-the-art biotech laboratories. During the last semester, practical training is followed by a research project to be carried out within research groups at CIBIO (Centre for Integrative Biology, University of Trento), or in one of the collaborating laboratories in other European universities, or in companies operating in the biotechnology or pharmaceutical sector. The MCMB program takes advantage of the long-term international relationships which globally connect the University of Trento, fostering a stimulating learning process.
Teaching activities include lectures, laboratory activities, and seminars. The program includes common core courses to be attended during the first year and two specialization tracks in cancer biology and in neurobiology during the first half of the second year.
Molecular basis of disease (12 credits) - Mandatory
Statistical methods for experimental sciences (6 credits) - Mandatory
Gene therapy (6 credits) - Mandatory
Cell therapy (6 credits) - Mandatory
Molecular pharmacology (6 credits) - Mandatory
Genomics and drug discovery (6 credits) - Mandatory
English (3 credits) - Mandatory
Cancer biology track
Cancer Biology (6 credits)
Cancer Therapy (6 credits)
Epigenetics of Cancer (6 credits)
Cellular and Molecular Neurobiology (6 credits)
Neurogenesis and Brain Regeneration (6 credits)
Functions of the Peripheral Nervous System (6 credits)
Microbes & Infection
Virus-Cell Interaction (6 credits)
Bacterial Pathogenesis (6 credits)
Applied Immunology (6 credits)
Elective courses (18 credits)
Stage/Internship (6 credits)
Research Seminars/Journal Club (3 credits)
Final thesis (30 credits)
Credits required to complete the MCMB program: 120 ECTS
Notes: according to the Sorbonne (1988) and the Bologna (1999) declarations university-level study programs in the European Higher Education Area are structured in university credits (ECTS). A university credit corresponds to 25 hours of student workload, time for personal preparation included. The annual average workload for a full-time student is conventionally fixed at 60 credits.
The Master’s degree program in Cellular and Molecular Biotechnology (MCMB) is designed to offer learning opportunities that enhance the skills and the competencies of professional biotechnologists:
Detailed knowledge of the functioning and regulation of prokaryotic and eukaryotic cells;
Methods for the structural and functional characterization of biological macromolecules and the cellular processes in which they are involved;
Detailed understanding of the pathological processes at the molecular, cellular, and systemic levels;
Technological skills for the design and manufacturing of biotechnology products and processes, such as biopharmaceuticals, diagnostics, and vaccines.
The Master’s degree program in Cellular and Molecular Biotechnology aims at shaping competitive biotechnologists, which are increasingly demanded in the medical, environmental, and industrial sectors. More specifically, career opportunities for students who graduated with an MCMB are to be found in a wide range of sectors, including:
Research and development in the biotechnology industry;
Technical-scientific information and communication;
Management of public and private institutions in biomedicine, diagnostics, cosmetics.
The MCMB allows students to embark upon international Ph.D. programs in Molecular Biology and Biotechnology, for those thinking of pursuing an academic or research career.
March for non-EU citizens living outside Italy
June for EU citizens and non-EU citizens regularly living in Italy
How to apply
Access the online application form
Upload the required documents
Submit your online application by the deadline
Bachelor’s degree (or equivalent) in Biotechnology or in any Biotechnology-related field
English at the B2 level of the Common European Framework of Reference for Languages
Assessment of previous studies and their coherence with the MSc
Statement of purpose